En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy

British Journal of Ophthalmology

Volumn 99, Issue 1, 2015, Pages 29-35

  Sayanagi, Kaori ^a   Gomi, Fumi ^a,b   Akiba, Masahiro ^c   Sawa, Miki ^a   Hara, Chikako ^a   Nishida, Kohji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b SUMITOMO HOSPITAL   (Japan)

^c TOPCON CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; COLORING AGENT; INDOCYANINE GREEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CHOROID THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTERMETHOD COMPARISON; MALE; NON INVASIVE PROCEDURE; OBSERVATIONAL STUDY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; POLYPOIDAL CHOROIDAL VASCULOPATHY; RETINA FOVEA; RETROSPECTIVE STUDY; SLIT LAMP; VISUAL SYSTEM PARAMETERS; CHOROID; CHOROIDAL NEOVASCULARIZATION; COMPARATIVE STUDY; DIAGNOSTIC USE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY; POLYPS; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROID; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; COMBINED MODALITY THERAPY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; MALE; PHOTOCHEMOTHERAPY; POLYPS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84919402549     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-304658     Document Type: Article

References (26)

1. Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990;10: 1-8.
2. Gomi F, Tano Y. Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol 2008;19: 208-12.
3. Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005;89: 602-7.
4. Iijima H, Iida T, Imai M, et al. Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2000;129: 21-6.
5. Otsuji T, Takahashi K, Fukushima I, et al. Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers 2000;31: 210-14.
6. Sato T, Kishi S, Watanabe G, et al. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 2007;27: 589-94.
7. Tsujikawa A, Sasahara M, Otani A, et al. Pigment epithelial detachment in polypoidal choroidal vasculopathy. Am J Ophthalmol 2007;143: 102-11.
8. Ojima Y, Hangai M, Sakamoto A, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 2009;29: 52-9.
9. Ueno C, Gomi F, Sawa M, et al. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy. Retina 2012;32: 2006-13.
10. Yasuno Y, Miura M, Kawana K, et al. Visualization of sub-retinal pigment epithelium morphologies of exudative macular diseases by high-penetration optical coherence tomography. Invest Ophthalmol Vis Sci 2009;50: 405-13.
11. Hong YJ, Miura M, Makita S, et al. Noninvasive investigation of deep vascular pathologies of exudative macular diseases by high-penetration optical coherence tomography. Invest Ophthalmol Vis Sci 2013;54: 3621-31.
12. Kameda T, Tsujikawa A, Otani A, et al. Polypoidal choroidal vasculopathy examined with en face optical coherence tomography. Clin Exp Ophthalmol 2007;35: 596-601.
13. Saito M, Iida T, Nagayama D. Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy. Retina 2008;28: 459-64.
14. Terasaki H, Miyake Y, Suzuki T, et al. Polypoidal choroidal vasculopathy treated with macular translocation: Clinical pathological correlation. Br J Ophthalmol 2002;86: 321-7.
15. MacCumber MW, Dastgheib K, Bressler NM, et al. Clinicopathologic correlation of the multiple recurrent serosanguineous retinal pigment epithelial detachment syndrome. Retina 1994;14: 143-52.
16. Sasahara M, Tsujikawa A, Musashi K, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 2006;142: 601-7.
17. Koizumi H, Yamagishi T, Yamazaki T, et al. Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability. Am J Ophthalmol 2013;155: 305-13.
18. Yannuzzi LA, Freund KB, Goldbaum M, et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000;107: 767-77.
19. Ueta T, Obata R, Inoue Y, et al. Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2009;116: 2004-6.
20. Koizumi H, Yamagishi T, Yamazaki T, et al. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Ophthalmol 2011;249: 1123-8.
21. Chung SE, Kang SW, Lee JH, et al. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 2011;118: 840-5.
22. Maruko I, Iida T, Sugano Y, et al. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2011;151: 594-603.
23. Ellabban AA, Tsujikawa A, Ogino K, et al. Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization. Clin Ophthalmol 2012;6: 837-44.
24. Sugano Y, Iida T, Maruko I, et al. Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2013;57: 294-300.
25. Yang LH, Jonas JB, Wei WB. Optical coherence tomographic enhanced depth imaging of polypoidal choroidal vasculopathy. Retina 2013;33: 1584-9.
26. Okubo A, Ito M, Sameshima M, et al. Pulsatile blood flow in the polypoidal choroidal vasculopathy. Ophthalmology 2005;112: 1436-41.